| Effect of hydrocortisone on mortality and organ support in patients with severe COVID-19: the REMAP-CAP COVID-19 corticosteroid domain randomized clinical trial DC Angus, L Derde, F Al-Beidh, D Annane, Y Arabi, A Beane, ... Jama 324 (13), 1317-1329, 2020 | 816 | 2020 |
| Interleukin-6 receptor antagonists in critically ill patients with Covid-19 Remap-Cap Investigators New England Journal of Medicine 384 (16), 1491-1502, 2021 | 602 | 2021 |
| Decision curve analysis M Fitzgerald, BR Saville, RJ Lewis Jama 313 (4), 409-410, 2015 | 549 | 2015 |
| Azithromycin for community treatment of suspected COVID-19 in people at increased risk of an adverse clinical course in the UK (PRINCIPLE): a randomised, controlled, open-label … CC Butler, J Dorward, LM Yu, O Gbinigie, G Hayward, BR Saville, ... The Lancet 397 (10279), 1063-1074, 2021 | 298 | 2021 |
| Inhaled budesonide for COVID-19 in people at high risk of complications in the community in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial LM Yu, M Bafadhel, J Dorward, G Hayward, BR Saville, O Gbinigie, ... The Lancet 398 (10303), 843-855, 2021 | 284 | 2021 |
| Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platform … CC Butler, FDR Hobbs, OA Gbinigie, NM Rahman, G Hayward, ... The Lancet 401 (10373), 281-293, 2023 | 269 | 2023 |
| Effect of convalescent plasma on organ support–free days in critically ill patients with COVID-19: a randomized clinical trial H Abdelhady, M Abdelrazik, Z Abdi, D Abdo, A Abdulle, L Abel, ... Jama 326 (17), 1690-1702, 2021 | 190 | 2021 |
| The phenotype of SCN8A developmental and epileptic encephalopathy E Gardella, C Marini, M Trivisano, MP Fitzgerald, M Alber, KB Howell, ... Neurology 91 (12), e1112-e1124, 2018 | 142 | 2018 |
| Analyzing 2,589 child neurology telehealth encounters necessitated by the COVID-19 pandemic SC Rametta, SE Fridinger, AK Gonzalez, J Xian, PD Galer, M Kaufman, ... Neurology 95 (9), e1257-e1266, 2020 | 127 | 2020 |
| Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial YM Arabi, AC Gordon, LPG Derde, AD Nichol, S Murthy, FA Beidh, ... Intensive care medicine 47, 867-886, 2021 | 86 | 2021 |
| Genotype-phenotype correlations in SCN8A-related disorders reveal prognostic and therapeutic implications KM Johannesen, Y Liu, M Koko, CE Gjerulfsen, L Sonnenberg, J Schubert, ... Brain 145 (9), 2991-3009, 2022 | 84 | 2022 |
| Long-term (180-day) outcomes in critically ill patients with COVID-19 in the REMAP-CAP randomized clinical trial S Florescu, D Stanciu, M Zaharia, A Kosa, D Codreanu, A Kidwai, ... Jama 329 (1), 39-51, 2023 | 81 | 2023 |
| Treatment Responsiveness in KCNT1-Related Epilepsy MP Fitzgerald, M Fiannacca, DM Smith, TS Gertler, B Gunning, S Syrbe, ... Neurotherapeutics 16, 848-857, 2019 | 72 | 2019 |
| Doxycycline for community treatment of suspected COVID-19 in people at high risk of adverse outcomes in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive … CC Butler, LM Yu, J Dorward, O Gbinigie, G Hayward, BR Saville, ... The Lancet Respiratory Medicine 9 (9), 1010-1020, 2021 | 70 | 2021 |
| Genome-wide studies reveal that H3K4me3 modification in bivalent genes is dynamically regulated during the pluripotent cell cycle and stabilized upon differentiation RA Grandy, TW Whitfield, H Wu, MP Fitzgerald, JJ VanOudenhove, ... Molecular and cellular biology 36 (4), 615-627, 2016 | 70 | 2016 |
| Effectiveness of tocilizumab, sarilumab, and anakinra for critically ill patients with COVID-19 the REMAP-CAP COVID-19 immune modulation therapy domain randomized clinical trial REMAP-CAP Investigators, LPG Derde, AC Gordon, PR Mouncey, ... MedRxiv, 2021.06. 18.21259133, 2021 | 59 | 2021 |
| Suppression of breast cancer stem cells and tumor growth by the RUNX1 transcription factor D Hong, AJ Fritz, KH Finstad, MP Fitzgerald, A Weinheimer, AL Viens, ... Molecular Cancer Research 16 (12), 1952-1964, 2018 | 56 | 2018 |
| Early discontinuation of antiseizure medications in neonates with hypoxic–ischemic encephalopathy MP Fitzgerald, SK Kessler, NS Abend Epilepsia 58 (6), 1047-1053, 2017 | 52 | 2017 |
| Bi-allelic ADARB1 variants associated with microcephaly, intellectual disability, and seizures TY Tan, J Sedmík, MP Fitzgerald, RS Halevy, LP Keegan, I Helbig, ... The American Journal of Human Genetics 106 (4), 467-483, 2020 | 42 | 2020 |
| KCNT1-related epilepsies and epileptic encephalopathies: phenotypic and mutational spectrum CM Bonardi, HO Heyne, M Fiannacca, MP Fitzgerald, E Gardella, ... Brain 144 (12), 3635-3650, 2021 | 41 | 2021 |
